"Alongside quarterly results, Vaxart said that its Phase II trial of VXA-CoV2-1, the company's vaccine encoding both the S and the N proteins, is now expected to start mid-year 2021 instead of in the second quarter. The delay is due to manufacturing issues at the Baltimore contract manufacturing facility, the same facility where other COVID-19 vaccine manufacturers have also reported issues, the company said."
Latest Comments
Apple Amidst US-China Wars
Exactly right, William.
Archegos Stocks Back To “Normal”
Back to normal? I think it's below normal.
I Will Wait To Hear Whether
Just a hunch... maybe they find you too difficult to work with.
The Word Is Getting Out
I thought you left?
DAX Forecast: Index Continues To Break Higher
Show me where we are higher please.
On A Whim
Lol, you sound just like Trump after taking his cognitive test. :-)
Extending Phase Two?
Interesting username you have there @[GoldPlatedDiapers](user:156485)! I prefer the solid gold kind myself.
Vaxart Slides After Reporting Delay Of Trial For Potential COVID-19 Oral Vaccine
"Alongside quarterly results, Vaxart said that its Phase II trial of VXA-CoV2-1, the company's vaccine encoding both the S and the N proteins, is now expected to start mid-year 2021 instead of in the second quarter. The delay is due to manufacturing issues at the Baltimore contract manufacturing facility, the same facility where other COVID-19 vaccine manufacturers have also reported issues, the company said."
We will be in the mid-year 2021 in June..
Do Not Gamble On Casino Stocks
With Covid far from over, I think online casino companies are the way to go. All those gambling addicts need to spend their money somewhere!
France Announces A New Four-Week Lockdown. The Stock Market Ignores The Situation In Europe
What else is new?